Colon Cancer Home > Capecitabine (Xeloda)

The U.S. Food and Drug Administration (FDA) has approved capecitabine (Xeloda®) to treat breast cancer and colorectal cancer (cancer of the colon or rectum). This medication is different from most other chemotherapy drugs in that it is given by mouth rather than intravenously. The tablets are generally taken twice a day, but certain factors can affect the dose you are prescribed.
Like most medicines used for chemotherapy, capecitabine can cause side effects, the most common of which are diarrhea, nausea, and vomiting. People with liver or kidney disease, as well as women who are pregnant or breastfeeding, may need to use a different product due to an increased risk for complications.
(Click Capecitabine to learn more about this drug, including how it works, what to do in cases of overdose, and important information for your healthcare provider.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.